{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:43:30Z","timestamp":1793371410516,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","seizure-journal.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.seizure.2019.10.006","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T16:18:45Z","timestamp":1571933925000},"page":"145-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Medical management of status epilepticus: Emergency room to intensive care unit"],"prefix":"10.1016","volume":"75","author":[{"given":"Ania A.","family":"Crawshaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah R.","family":"Cock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2019.10.006_bib0005","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.10.006_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2010.09.003","article-title":"Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: a review","volume":"93","author":"Neligan","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2019.10.006_bib0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/CCM.0000000000002843","article-title":"Acute systemic complications of convulsive status epilepticus-a systematic review","volume":"46","author":"Sutter","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.seizure.2019.10.006_bib0020","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2017.4382","article-title":"Association of time to treatment with short-term outcomes for pediatric patients with refractory convulsive status epilepticus","volume":"75","author":"Gainza-Lein","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2019.10.006_bib0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.yebeh.2018.09.046","article-title":"Cost of status epilepticus (SE): effects of delayed treatment and SE duration","volume":"89","author":"Santamarina","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2019.10.006_bib0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1157.1994.tb02908.x","article-title":"Determinants of mortality in status epilepticus","volume":"35","author":"Towne","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.10.006_bib0035","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1469-8749.1997.tb07358.x","article-title":"Status epilepticus in children: aetiology, treatment, and outcome","volume":"39","author":"Eriksson","year":"1997","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.seizure.2019.10.006_bib0040","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s004150050260","article-title":"Generalized tonic-clonic status epilepticus: causes, treatment, complications and predictors of case fatality","volume":"245","author":"Sagduyu","year":"1998","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2019.10.006_bib0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02760691","article-title":"Status epilepticus in Indian children in a tertiary care center","volume":"72","author":"Gulati","year":"2005","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.seizure.2019.10.006_bib0050","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1528-1167.2008.01993.x","article-title":"Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours","volume":"50","author":"Drislane","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.10.006_bib0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1684\/epd.2016.0855","article-title":"Prognostic factors of status epilepticus in adults","volume":"18","author":"Power","year":"2016","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2019.10.006_bib0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.seizure.2018.10.003","article-title":"Can home videos made on smartphones complement video-EEG in diagnosing psychogenic nonepileptic seizures?","volume":"62","author":"Ramanujam","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2019.10.006_bib0065","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1212\/01.WNL.0000113755.11398.90","article-title":"Failure to recognize psychogenic nonepileptic seizures may cause death","volume":"62","author":"Reuber","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2019.10.006_bib0070","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1111\/epi.12356","article-title":"Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach A report from the International League Against Epilepsy Nonepileptic Seizures Task Force","volume":"54","author":"LaFrance","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.10.006_bib0075","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/jnnp.2009.197996","article-title":"Does the primary literature provide support for clinical signs used to distinguish psychogenic nonepileptic seizures from epileptic seizures?","volume":"81","author":"Avbersek","year":"2010","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.seizure.2019.10.006_bib0080","doi-asserted-by":"crossref","first-page":"414","DOI":"10.7861\/clinmedicine.18-5-414","article-title":"Functional neurological disorders: acute presentations and management","volume":"18","author":"Cock","year":"2018","journal-title":"Clin Med"},{"key":"10.1016\/j.seizure.2019.10.006_bib0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the american epilepsy society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.seizure.2019.10.006_bib0090","series-title":"Drug management for acute tonic\u2010clonic convulsions including convulsive status epilepticus in children. Cochrane Database of Systematic Reviews","author":"McTague","year":"2018"},{"key":"10.1016\/j.seizure.2019.10.006_bib0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jocn.2015.10.038","article-title":"Lorazepam or diazepam for convulsive status epilepticus: a meta-analysis","volume":"29","author":"Wu","year":"2016","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.seizure.2019.10.006_bib0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yebeh.2016.09.020","article-title":"Is intravenous lorazepam really more effective and safe than intravenous diazepam as first-line treatment for convulsive status epilepticus? A systematic review with meta-analysis of randomized controlled trials","volume":"64","author":"Brigo","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2019.10.006_bib0105","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/epi.13056","article-title":"Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: a multicenter comparison","volume":"56","author":"Alvarez","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.10.006_bib0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1474-4422(15)00296-3","article-title":"Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial","volume":"15","author":"Navarro","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2019.10.006_bib0115","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2019.10.006_bib0120","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.yebeh.2015.02.030","article-title":"Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: a systematic review with meta-analysis","volume":"49","author":"Brigo","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2019.10.006_bib0125","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1212\/WNL.0000000000002142","article-title":"Efficacy of nonvenous medications for acute convulsive seizures: a network meta-analysis","volume":"85","author":"Arya","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2019.10.006_bib0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.yebeh.2016.07.018","article-title":"Benzodiazepine use in seizure emergencies: a systematic review","volume":"63","author":"Haut","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2019.10.006_bib0135","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2019.10.006_bib0140","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/01.wnl.0000224880.35053.26","article-title":"Sodium valproate vs phenytoin in status epilepticus: a pilot study","volume":"67","author":"Misra","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2019.10.006_bib0145","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1600-0404.2008.01097.x","article-title":"Treatment of status epilepticus and acute repetitive seizures with i.v. Valproic acid vs phenytoin","volume":"118","author":"Gilad","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2019.10.006_bib0150","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.pediatrneurol.2011.07.007","article-title":"Comparative efficacy and safety of intravenous valproate and phenytoin in children","volume":"45","author":"Rai","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2019.10.006_bib0155","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00415-011-6227-2","article-title":"Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study","volume":"259","author":"Misra","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2019.10.006_bib0160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.seizure.2013.12.007","article-title":"The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies","volume":"23","author":"Yasiry","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2019.10.006_bib0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/epi.12288","article-title":"The established status epilepticus trial 2013","volume":"54","author":"Bleck","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.10.006_bib0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.eplepsyres.2016.08.016","article-title":"Status epilepticus in the elderly-A retrospective study on 120 patients","volume":"127","author":"Rohracher","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2019.10.006_bib0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.yebeh.2017.04.019","article-title":"Adjunctive eslicarbazepine acetate: a pooled analysis of three phase III trials","volume":"72","author":"Biton","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2019.10.006_bib0180","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.annemergmed.2003.10.011","article-title":"Cost-effectiveness of oral phenytoin, intravenous phenytoin, and intravenous fosphenytoin in the emergency department","volume":"43","author":"Rudis","year":"2004","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.seizure.2019.10.006_bib0185","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1592\/phco.19.10.844.31556","article-title":"Phenytoin and fosphenytoin: a model of cost and clinical outcomes","volume":"19","author":"Armstrong","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.seizure.2019.10.006_bib0190","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40263-014-0167-1","article-title":"Efficacy and safety of intravenous valproate for status epilepticus: a systematic review","volume":"28","author":"Trinka","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2019.10.006_bib0195","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.46.2.465","article-title":"Valproic acid hepatic fatalities .3. US experience since 1986","volume":"46","author":"Bryant","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2019.10.006_bib0200","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.seizure.2007.04.012","article-title":"Randomized study of intravenous valproate and phenytoin in status epilepticus","volume":"16","author":"Agarwal","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2019.10.006_bib0205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eplepsyres.2015.04.003","article-title":"Intravenous levetiracetam treatment in status epilepticus: a prospective study","volume":"114","author":"Atmaca","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2019.10.006_bib0210","article-title":"The use of intravenous levetiracetam in status epilepticus and acute seizure emergencies","volume":"49","author":"Trinka","year":"2008","journal-title":"Epilepsia"},{"issue":"10186","key":"10.1016\/j.seizure.2019.10.006_bib0215","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","article-title":"Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial","volume":"393","author":"Lyttle","year":"2019","journal-title":"The Lancet"},{"issue":"10186","key":"10.1016\/j.seizure.2019.10.006_bib0220","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","article-title":"Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial","volume":"393","author":"Dalziel","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.seizure.2019.10.006_bib0225","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1684\/epd.2013.0601","article-title":"A common reference-based indirect comparison meta-analysis of intravenous valproate versus intravenous phenobarbitone for convulsive status epilepticus","volume":"15","author":"Brigo","year":"2013","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2019.10.006_bib0230","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s40263-016-0388-6","article-title":"Phenobarbital versus valproate for generalized convulsive status epilepticus in adults: a prospective randomized controlled trial in China","volume":"30","author":"Su","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2019.10.006_bib0235","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.yebeh.2016.09.030","article-title":"Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus","volume":"64","author":"Brigo","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2019.10.006_bib0240","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/epi.13716","article-title":"Lacosamide in status epilepticus: systematic review of current evidence","volume":"58","author":"Strzelczyk","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.10.006_bib0245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yebeh.2018.04.025","article-title":"Intravenous lacosamide (LCM) in status epilepticus (SE): weight-adjusted dose and efficacy","volume":"84","author":"Santamarina","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2019.10.006_bib0250","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.yebeh.2017.07.005","article-title":"Comparison of lacosamide versus sodium valproate in status epilepticus: a pilot study","volume":"76","author":"Misra","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2019.10.006_bib0255","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/ana.25249","article-title":"Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures","volume":"83","author":"Husain","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2019.10.006_bib0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eplepsyres.2016.12.015","article-title":"Lacosamide for uncontrolled primary generalized tonic-clonic seizures: an open-label pilot study with 59-week extension","volume":"130","author":"Wechsler","year":"2017","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2019.10.006_bib0265","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40263-017-0424-1","article-title":"Newer antiepileptic drugs in status epilepticus: prescription trends and outcomes in comparison with traditional agents","volume":"31","author":"Beuchat","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2019.10.006_bib0270","article-title":"Brivaracetam in established status epilepticus: the Salzburg experience","volume":"58","author":"Kalss","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.10.006_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2016.04.003","article-title":"Successful treatment of super-refractory tonic status epilepticus with rufinamide: first clinical report","volume":"39","author":"Thompson","year":"2016","journal-title":"Seizure-European Journal of Epilepsy"},{"key":"10.1016\/j.seizure.2019.10.006_bib0280","first-page":"117","article-title":"Standards of care for non-convulsive status epilepticus: belgian consensus recommendations","volume":"106","author":"van Rijckevorsel","year":"2006","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.seizure.2019.10.006_bib0285","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.seizure.2018.04.005","article-title":"Outcomes of deviation from treatment guidelines in status epilepticus: a systematic review","volume":"58","author":"Uppal","year":"2018","journal-title":"Seizure-Eur J Epilepsy"},{"key":"10.1016\/j.seizure.2019.10.006_bib0290","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/0883073812474950","article-title":"A computerized standard protocol order entry for pediatric inpatient acute seizure emergencies reduces time to treatment","volume":"29","author":"Xie","year":"2014","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2019.10.006_bib0295","series-title":"General Medical Council: Making and using visual and audio recordings of patients","year":"2011"},{"key":"10.1016\/j.seizure.2019.10.006_bib0300","series-title":"National Patient Safety Agency, Rapid Response Report NSPA\/2010\/RRR018. Preventing Fatalities form medication loading doses","year":"2010"},{"key":"10.1016\/j.seizure.2019.10.006_bib0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.04.049","article-title":"Lessons from the Established Status Epilepticus Treatment Trial","author":"Cock","year":"2019","journal-title":"Epilepsy and Behaviour"},{"issue":"8","key":"10.1016\/j.seizure.2019.10.006_bib0310","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/acem.13811","article-title":"Underdosing of Benzodiazepines in Patients With Status Epilepticus Enrolled in Established Status Epilepticus Treatment Trial","volume":"26","author":"Sathe","year":"2019","journal-title":"Academic Emergency Medicine"}],"updated-by":[{"DOI":"10.1016\/j.seizure.2020.05.021","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000}}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131119302043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131119302043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T02:48:41Z","timestamp":1612147721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131119302043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":62,"alternative-id":["S1059131119302043"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2019.10.006","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.seizure.2020.05.021","asserted-by":"object"}]},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical management of status epilepticus: Emergency room to intensive care unit","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2019.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}